全球戒烟和尼古丁成瘾治疗产品市场按给药途径、产品、通路和地区划分

2025 年全球戒烟和尼古丁成瘾治疗产品市场规模估计为 194.1 亿美元，预计到 2032 年将达到 593.6 亿美元，2025 年至 2032 年的复合年增长率为 17.3%。

市场占有率。

由于世界吸烟人口的增加和对吸烟健康危害的认识不断提高，全球戒烟和尼古丁成瘾治疗产品市场正在经历显着增长。吸烟已成为全球公共卫生问题，世界卫生组织（WHO）建议采取一系列措施帮助人们戒烟。尼古丁替代疗法和其他戒烟辅助手段已被证明能有效帮助吸烟者戒除烟瘾。各国政府和非政府组织所进行的多项宣传宣传活动增加了对尼古丁口香糖、贴片、含片和处方药的需求，以帮助人们戒烟。产品配方和新技术的进步正在扩大想要戒烟的吸烟者的选择。然而，某些戒烟产品的高成本以及烟瘾的持续存在给该行业带来了挑战。

市场动态：

全球戒烟和尼古丁成瘾治疗产品市场的成长得益于吸烟相关疾病的日益流行、消费者健康意识的不断增强以及政府当局为遏制烟草使用而采取的各种倡议。然而，某些戒烟疗法的高成本以及烟草业强烈反对产品监管的游说正在抑制市场的成长。此外，数位化解决方案在戒烟治疗中的广泛应用也带来了新的机会。已经开发了各种行动应用程式和线上程式来提高尼古丁替代疗法和消费者行为支援的有效性。尼古丁替代递送形式的创新也是日益受到关注的一大趋势。

本研究的主要特点

• 本报告对全球戒烟和尼古丁成瘾治疗产品市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和復合年增长率。
• 它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。
• 它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
• 报告深入分析了全球戒烟和尼古丁成瘾治疗产品市场的主要企业格局，包括其产品系列、主要亮点、业务表现和策略。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球戒烟和尼古丁成瘾治疗产品市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过用于分析全球戒烟和尼古丁成瘾治疗产品市场的各种策略矩阵来简化决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管情景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

4. 全球戒烟与尼古丁成瘾治疗产品市场：COVID-19 疫情的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 全球戒烟和尼古丁成瘾治疗产品市场依给药途径划分（2020-2032 年）

• 口服
• 经皮
• 鼻腔
• 舌下

6. 全球戒烟和尼古丁成瘾治疗产品市场（按产品划分）（2020-2032 年）

• 尼古丁替代疗法
• 尼古丁喷雾
• 尼古丁吸入器
• 尼古丁口香糖
• 尼古丁经皮吸收贴片
• 尼古丁舌下片
• 尼古丁含片
• 药物治疗
• Varenicline
• Zyban
• 尼可莱特·巴卡尔
• 电子烟/电子液体

7. 全球戒烟和尼古丁成瘾治疗产品市场按分销管道划分（2020-2032 年）

• 院内药房
• 网路药局
• 零售药局

8. 全球戒烟和尼古丁成瘾治疗产品市场（按地区） (2020-2032)

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第九章 竞争格局

• 公司简介
  • GlaxoSmithKline plc（GSK）
  • Pfizer Inc.
  • Johnson &Johnson
  • Novartis International AG
  • Imperial Brands plc
  • British American Tobacco plc（BAT）
  • Cipla Inc.
  • McNeil AB
  • NJOY, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Perrigo Company plc
  • Fertin Pharma
  • Philip Morris International Inc.
  • Alkalon A/S
  • Japan Tobacco Inc.
  • Nicotek, LLC
  • 22nd Century Group Inc.

第 10 章分析师建议

• 命运之轮
• 分析师观点
• Coherent Opportunity Map（COM）

第 11 章 参考文献与调查方法

• 参考
• 调查方法

Global Smoking Cessation and Nicotine De-addiction Products Market is estimated to be valued at USD 19.41 Bn in 2025 and is expected to reach USD 59.36 Bn by 2032, growing at a compound annual growth rate (CAGR) of 17.3% from 2025 to 2032.

Figure. Smoking Cessation And Nicotine De-addiction Products Market Share (%), By Region 2025

The global market for smoking cessation and nicotine de-addiction products is growing significantly owing to the rising global population of smokers and increasing awareness about health hazards of smoking. Smoking has become a worldwide public health issue and the World Health Organization (WHO) recommends various measures to help people quit tobacco consumption. Nicotine replacement therapies and other smoking cessation aids are proving effective in assisting smokers to break the habit. Several awareness campaigns by governments and NGOs have boosted the demand for nicotine gums, patches, lozenges and prescription medications for quitting smoking. Advancements in product formulations and newer technologies are expanding the choices available to smokers who want to quit. However, high prices of certain de-addiction products and persistence of tobacco addiction pose challenges to the industry.

Market Dynamics:

The global smoking cessation and nicotine de-addiction products market growth is driven by the increasing prevalence of smoking-related diseases, growing health consciousness among consumers, and various initiatives by public organizations to curb tobacco use. However, high costs of certain smoking cessation therapies, along with strong tobacco industry lobbying against product regulations, are restraining the market growth. The widespread adoption of digital solutions for smoking cessation therapies is opening new opportunities. Various mobile apps and online programs are being developed to improve the effectiveness of nicotine replacement therapies and behavioral support for consumers. Innovation in alternate delivery forms of nicotine is another key trend gaining traction.

Key Features of the Study:

• This report provides in-depth analysis of the global smoking cessation and nicotine de-addiction products market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global smoking cessation and nicotine de-addiction products market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GlaxoSmithKline, Pfizer, Johnson & Johnson, and Dr. Reddy's Laboratories
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global smoking cessation and nicotine de-addiction products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smoking cessation and nicotine de-addiction products market.

Detailed Segmentation-

• By Route of Administration
  • Oral
  • Transdermal
  • Nasal
  • Sublingual
  • Oral
• By Product
  • Nicotine Replacement Therapy
  • Nicotine Spray
  • Nicotine Inhalers
  • Nicotine Gum
  • Nicotine Transdermal Patches
  • Nicotine Sublingual Tablets
  • Nicotine Lozenges
  • Drug Therapy
  • Varenicline
  • Zyban
  • Nicorette Buccal
  • E-cigarettes/E-liquid
• By Distribution Channel
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • GlaxoSmithKline plc (GSK)
  • Pfizer Inc.
  • Johnson & Johnson
  • Novartis International AG
  • Imperial Brands plc
  • British American Tobacco plc (BAT)
  • Cipla Inc.
  • McNeil AB
  • NJOY, Inc.
  • Reddy's Laboratories Ltd.
  • Perrigo Company plc
  • Fertin Pharma
  • Philip Morris International Inc.
  • Alkalon A/S
  • Japan Tobacco Inc.
  • Nicotek, LLC
  • 22nd Century Group Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Product
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Smoking Cessation and Nicotine De-addiction Products Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Smoking Cessation and Nicotine De-addiction Products Market, By Route of Administration, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Transdermal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nasal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sublingual
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Smoking Cessation and Nicotine De-addiction Products Market, By Product, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Nicotine Replacement Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nicotine Spray
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nicotine Inhalers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nicotine Gum
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nicotine Transdermal Patches
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nicotine Sublingual Tablets
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nicotine Lozenges
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Drug Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Varenicline
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Zyban
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nicorette Buccal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• E-cigarettes/E-liquid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Smoking Cessation and Nicotine De-addiction Products Market, By Distribution Channel, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospital Pharmacy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Smoking Cessation and Nicotine De-addiction Products Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • GlaxoSmithKline plc (GSK)
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer Inc.
  • Johnson & Johnson
  • Novartis International AG
  • Imperial Brands plc
  • British American Tobacco plc (BAT)
  • Cipla Inc.
  • McNeil AB
  • NJOY, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Perrigo Company plc
  • Fertin Pharma
  • Philip Morris International Inc.
  • Alkalon A/S
  • Japan Tobacco Inc.
  • Nicotek, LLC
  • 22nd Century Group Inc.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact